Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
An Open Label, Phase 1/2 Study Evaluating Immunomodulatory AVM0703 in Patients With Lymphoid Malignancies (OPAL Study)
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 a…
Lymphoid Malignancies
AVM Biotechnology IncNCT04329728
Phase 1
Feasibility Study of CD34 Selection for GVHD Prophylaxis Using the Automated CliniMACS
Patients with graft failure or delayed engraftment may benefit from a hematopoietic stem cell boost or an additional hematopoietic stem cell transplantation pr…
AMLALLLymphoid Malignancies+3 more
University of Alabama at BirminghamNCT06047886